These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 65115)

  • 1. Control of proliferative growth in androgen responsive organs and neoplasms.
    Bruchovsky N; Lesser B
    Adv Sex Horm Res; 1976; 2():1-55. PubMed ID: 65115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoplasmic and nuclear androgen receptors of human prostate.
    Shain SA; Boesel RW; Radwin HM; Lamm DL
    Prog Clin Biol Res; 1979; 33():33-49. PubMed ID: 93751
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of FGF8 expression by the androgen receptor in human prostate cancer.
    Gnanapragasam VJ; Robson CN; Neal DE; Leung HY
    Oncogene; 2002 Aug; 21(33):5069-80. PubMed ID: 12140757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability of androgen-related phenotypes in the Shionogi mammary carcinoma during growth, involution, recurrence, and progression to hormonal independence.
    Bruchovsky N; Rennie PS; Otal N; Vanson A; Giles M; Pontifex H
    Cancer Res; 1985 Feb; 45(2):682-9. PubMed ID: 3967243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin influences upon androgen action in male accessory sex organs.
    Thomas JA; Keenan EJ
    Adv Sex Horm Res; 1976; 2():425-70. PubMed ID: 189591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
    Joseph IB; Nelson JB; Denmeade SR; Isaacs JT
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2507-11. PubMed ID: 9815654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal effects on cell proliferation in rat prostate.
    Bruchovsky N; Lesser B; Van Doorn E; Craven S
    Vitam Horm; 1975; 33():61-102. PubMed ID: 180681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.
    Trachtenberg J; Hicks LL; Walsh PC
    J Clin Invest; 1980 May; 65(5):1051-9. PubMed ID: 6154062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.
    Bonkhoff H; Remberger K
    Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity.
    Siu SW; Lau KW; Tam PC; Shiu SY
    Prostate; 2002 Jul; 52(2):106-22. PubMed ID: 12111702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen sensitivity of prostate epithelium is enhanced by postnatal androgen receptor inactivation.
    Simanainen U; McNamara K; Gao YR; Handelsman DJ
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1335-43. PubMed ID: 19366880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen and prostatic stroma.
    Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
    Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hic-5/ARA55, a LIM domain-containing nuclear receptor coactivator expressed in prostate stromal cells.
    Heitzer MD; DeFranco DB
    Cancer Res; 2006 Jul; 66(14):7326-33. PubMed ID: 16849583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A differential ligand-mediated response of green fluorescent protein-tagged androgen receptor in living prostate cancer and non-prostate cancer cell lines.
    Nakauchi H; Matsuda K; Ochiai I; Kawauchi A; Mizutani Y; Miki T; Kawata M
    J Histochem Cytochem; 2007 Jun; 55(6):535-44. PubMed ID: 17312014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways.
    Vis AN; Schröder FH
    BJU Int; 2009 Aug; 104(4):438-48. PubMed ID: 19558559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle regulator cdk2ap1 inhibits prostate cancer cell growth and modifies androgen-responsive pathway function.
    Zolochevska O; Figueiredo ML
    Prostate; 2009 Oct; 69(14):1586-97. PubMed ID: 19585490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of rat prostate stromal cell myodifferentiation by androgen and TGF-beta1.
    Gerdes MJ; Larsen M; Dang TD; Ressler SJ; Tuxhorn JA; Rowley DR
    Prostate; 2004 Feb; 58(3):299-307. PubMed ID: 14743470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular mechanisms of the action of androgens].
    Minchenko AG; Tron'ko ND
    Fiziol Zh (1978); 1985; 31(6):717-29. PubMed ID: 2416600
    [No Abstract]   [Full Text] [Related]  

  • 19. Androgen receptor isoforms in human and rat prostate.
    Xia SJ; Hao GY; Tang XD
    Asian J Androl; 2000 Dec; 2(4):307-10. PubMed ID: 11202423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
    Carruba G
    J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.